2022 Fiscal Year Annual Research Report
多次元脳神経画像とゲノムによる精神疾患の脳病態に基づく新たな診断体系の構築
Project/Area Number |
20H03611
|
Research Institution | National Center of Neurology and Psychiatry |
Principal Investigator |
橋本 亮太 国立研究開発法人国立精神・神経医療研究センター, 精神保健研究所 精神疾患病態研究部, 部長 (10370983)
|
Co-Investigator(Kenkyū-buntansha) |
松本 純弥 国立研究開発法人国立精神・神経医療研究センター, 精神保健研究所 精神疾患病態研究部, 室長 (10635535)
三浦 健一郎 国立研究開発法人国立精神・神経医療研究センター, 精神保健研究所 精神疾患病態研究部, 室長 (20362535)
長谷川 尚美 国立研究開発法人国立精神・神経医療研究センター, 精神保健研究所 精神疾患病態研究部, リサーチフェロー (70865906)
|
Project Period (FY) |
2020-04-01 – 2023-03-31
|
Keywords | 統合失調症 / 精神疾患 / 脳神経画像 / MRI / 大脳皮質下体積 / 大脳皮質厚 / 大脳皮質面積 |
Outline of Annual Research Achievements |
本研究では、多施設で大規模に統合失調症、双極性障害、うつ病、自閉スペクトラム症の脳神経画像を収集し、年齢、性別などを共変量として、メタアナリシスを行う。大脳皮質下体積や大脳皮質厚を検討し、精神疾患横断的に、統合失調症、双極性障害、うつ病、自閉スペクトラム症において、疾患特異的な異常及び疾患に共通する脳病態を同定する。既存の精神疾患の客観的診断基準に資する成果を得るだけでなく、脳病態に基づく新たな診断体系モデルの構築を目的とする。 本年度は日本の多施設共同研究によりSZ、BD、MD、ASDの大脳皮質構造のメガ解析を実施し、各疾患の類似度を検討した。認知ゲノム共同研究機構(COCORO)から、SZ群1450名、BD群235名、MD群570名、ASD群195名、健常群2933名が参加した。T1強調磁気共鳴画像を得てFreeSurferにより大脳皮質厚と大脳皮質面積を算出しメタ解析した。SZ群では健常群と比較して大脳皮質厚が全般的な菲薄化を認め、同様に大脳皮質面積も全般的に減少していた。BD群では大脳皮質厚については健常群と比較して68領域中34領域で有意に菲薄化していたが、大脳皮質面積については健常群と比較して有意な減少は見られなかった。MD群では大脳皮質の菲薄化が68領域中30領域で認められ、大脳皮質面積減少は11領域で認められた。ASD群では大脳皮質厚も大脳皮質面積も有意差がなかった。これらの疾患の大脳皮質厚菲薄化パターンと大脳皮質面積減少パターンをコサイン類似度で分類した。大脳皮質厚の菲薄化パターンはSZ群、MD群、BD群で類似していた。大脳皮質面積減少パターンはSZ群、MD群、ASD群で類似していた。皮質厚、皮質面積の類似度が精神疾患の病態を示すバイオタイプになる可能性が示された。
|
Research Progress Status |
令和4年度が最終年度であるため、記入しない。
|
Strategy for Future Research Activity |
令和4年度が最終年度であるため、記入しない。
|
-
-
-
[Journal Article] Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.2023
Author(s)
Fukumoto K, Kodaka F, Hasegawa N, (28名中略) Matsumoto J, Miura K, Yamada H, Yasui-Furukori N, Watanabe K, Inada K, Otsuka K, Hashimoto R.
-
Journal Title
Neuropsychopharmacol Rep
Volume: 43(1)
Pages: 33-39
DOI
Peer Reviewed / Open Access
-
[Journal Article] Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders.2023
Author(s)
Yamagata H, Tsunedomi R, Kamishikiryo T, Kobayashi A, Seki T, Kobayashi M, Hagiwara K, Yamada N, Chen C, Uchida S, Ogihara H, Hamamoto Y, Okada G, Fuchikami M, Iga JI, Numata S, Kinoshita M, Kato TA, Hashimoto R, Nagano H, Ueno S, Okamoto Y, Ohmori T, Nakagawa S.
-
Journal Title
Heliyon
Volume: 9(1)
Pages: e13059
DOI
Peer Reviewed / Open Access
-
[Journal Article] Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis.2023
Author(s)
Tsuboi T, Takaesu Y, Hasegawa N, (27名中略)Matsumoto J, Miura K, Hishimoto A, Numata S, Yamada H, Yasui-Furukori N, Inada K, Watanabe K, Hashimoto R.
-
Journal Title
Psychiatry Clin Neurosci
Volume: 77(1)
Pages: 30-37
DOI
Peer Reviewed / Open Access
-
-
[Journal Article] Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia".2022
Author(s)
Inada K, Fukumoto K, Hasegawa N, (25名中略) Matsumoto J, Miura K,Usami M, Kishimoto T, Onitsuka T, Katsumoto E, Hishimoto A, Numata S, Yasui- Furukori N, Watanabe K, *Hashimoto R.
-
Journal Title
Neuropsychopharmacol Rep
Volume: 42(4)
Pages: 502-509
DOI
Peer Reviewed / Open Access
-
-
[Journal Article] X chromosome aneuploidies and schizophrenia: association analysis and phenotypic characterization.2022
Author(s)
Kushima I, Aleksic B, Kimura H, Nakatochi M, Lo T, Ikeda M, Arai M, Hashimoto R, Numata S, Okamura Y, Obara T, Inada T, Ozaki N.
-
Journal Title
Psychiatry Clin Neurosci
Volume: 76(12)
Pages: 667-673
DOI
Peer Reviewed / Open Access
-
-
-
[Journal Article] Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.2022
Author(s)
Ochi S, Tagata H, Hasegawa N, (25名中略) Matsumoto J, Miura K, Kido M, Hishimoto A, Ueno SI, Watanabe K, Inada K, Hashimoto R.
-
Journal Title
Int J Neuropsychopharmacol
Volume: 25(10)
Pages: 818-826
DOI
Peer Reviewed / Open Access
-
-
-
[Journal Article] Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study.2022
Author(s)
Muraoka H, Kodaka F, Hasegawa N, (27名中略) Miura K, Matsumoto J, Ohi K, Yamada H, Watanabe K, Inada K, Nishimura K, Hashimoto R.
-
Journal Title
Asian Jornal of psychiatry
Volume: 74
Pages: 103174
DOI
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre study.2022
Author(s)
Sumiyoshi C, Ohi K, Fujino H, Yamamori H, Fujimoto M, Yasuda Y, Uno Y, Takahashi J, Morita K, Katsuki A, Yamamoto M, Okahisa Y, Sata A, Katsumoto E, Koeda M, Hirano Y, Nakataki M, Matsumoto J, Miura K, Hashimoto N, Makinodan M, Takahashi T, Nemoto K, Kishimoto T, Suzuki M, Sumiyoshi T, Hashimoto R.
-
Journal Title
BJ Psych Open
Volume: 8(4)
Pages: e98
DOI
Peer Reviewed / Open Access
-
[Journal Article] Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study.2022
Author(s)
Takahashi T, Tsugawa S, Nakajima S, Plitman E, Chakravarty MM, Masuda F, Wada M, Kurose S, Ochi R, Matsushita K, Sasabayashi D, Nakamura M, Nishikawa Y, Takayanagi Y, Nishiyama S, Higuchi Y, Mizukami Y, Furuichi A, Kido M, Hashimoto R, Noguchi K, Fujii S, Mimura M, Noda Y, Suzuki M.
-
Journal Title
Schizophr Res
Volume: 243
Pages: 268-275
DOI
Peer Reviewed / Open Access
-
[Journal Article] Prescription of anticholinergic drugs in patients with schizophrenia: analysis of antipsychotic prescription patterns and hospital characteristics.2022
Author(s)
Hori H, Yasui-Furukori N, Hasegawa N, (29名中略) Matsumoto J, Kubota C, Miura K, Hishimoto A, Watanabe K, Inada K, Kawasaki H, Hashimot R.
-
Journal Title
Front Psychiatry, section Psychopharmacology
Volume: 13
Pages: 823826
DOI
Peer Reviewed / Open Access
-
[Journal Article] Sex differences in social cognition and association of social cognition and neurocognition in early course schizophrenia.2022
Author(s)
Kubota R, Okubo R, Ikezawa S, Matsui M, Adachi L, Wada A, Fujimaki C, Yamada Y, Saeki K, Sumiyoshi C, Kikuchi A, Omachi Y, Takeda K, Hashimoto R, Sumiyoshi T, Yoshimura N.
-
Journal Title
Front Psychiatry, section Psychopathology
Volume: 13
Pages: 867468
DOI
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Toward recovery in schizophrenia: Current concepts, findings, and future research directions.2022
Author(s)
Onitsuka T, Hirano Y, Nakazawa T, Ichihashi K, Miura K, Inada K, Mitoma R, Yasui-Furukori N, Hashimoto R.
-
Journal Title
Psychiatry Clin Neurosci
Volume: 76(7)
Pages: 282-291
DOI
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Impaired neurodevelopment in iPS cell-derived neural stem cells from psychiatric patients with 7q36.3 microduplication,2022
Author(s)
Kitagawa K, Baba M, Takemoto T, Nagayasu K, Kasai A, Takuma K, Hashimoto R, Hashimoto H, Ago Y, Nakazawa T,
Organizer
VPAC-ISBAP2022(The 15th International Symposium on VIP, PACAP and Related Peptides The 1st International Society for BioactivePeptides Meeting)
Int'l Joint Research
-
[Presentation] Large-scale analysis of brain structural asymmetries in schizophrenia via the ENIGMA consortium.2022
Author(s)
Schijven D, Postema MC, ENIGMA-Schizophrenia Working Group, Fisher SE, Franke B, Glahn DC, Gur RC, Hashimoto R, Jahanshad N, Luders E, Medland SE, Thompson PM, Turner JA, van Erp TGM, Francks C.
Organizer
2022 OHBM Annual Meeting
Int'l Joint Research
-
[Presentation] Polygenic risk scores differentiating schizophrenia from bipolar disorder are associated with premorbid intelligence in schizophrenia patients and healthy subjects.2022
Author(s)
Ohi K, Nishizawa D, Sugiyama S, Takai K, Kuramitsu A, Hasegawa J, Soda M, Kitaichi K, Hashimoto R, Ikeda K, Shioiri T.
Organizer
2022 Congress of the Schizophrenia International Research Society
Int'l Joint Research
-
[Presentation] Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: A real-world nationwide study.2022
Author(s)
Ochi S, Tagata H, Hasegawa H, (25名中略) Matsumoto J, Miura K, Kido M, Hishimoto A, Ueno S, Watanabe K, Inada K, Hashimoto R.
Organizer
CINP(33rd Committee of the International College of Neuropsychopharmacology)
Int'l Joint Research
-
[Presentation] Cognitive Performances across Individuals at High Genetic Risk for Schizophrenia, High Genetic Risk for Bipolar Disorder, and Low Genetic Risks: A Combined Polygenic Risk Score Approach.2022
Author(s)
Ohi K, Nishizawa D, Sugiyama S, Takai K, Fujikane D, Kuramitsu A, Hasegawa J, Soda M, Kitaichi K, Hashimoto R, Ikeda K, Shioiri T.
Organizer
CINP(33rd Committee of the International College of Neuropsychopharmacology)
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-